Susan Nmn Ungar

Array ( [id] => 3683020 [patent_doc_number] => 05662911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Benzodiazepine protein conjugates' [patent_app_type] => 1 [patent_app_number] => 8/590830 [patent_app_country] => US [patent_app_date] => 1996-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4921 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/662/05662911.pdf [firstpage_image] =>[orig_patent_app_number] => 590830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4083987 [patent_doc_number] => 06025191 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Isolated nucleic acid molecules which encode a melanoma specific antigen and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/580980 [patent_app_country] => US [patent_app_date] => 1996-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7356 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025191.pdf [firstpage_image] =>[orig_patent_app_number] => 580980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3780693 [patent_doc_number] => 05821065 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Immunoassay for the detection of collagen I' [patent_app_type] => 1 [patent_app_number] => 8/576039 [patent_app_country] => US [patent_app_date] => 1995-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6789 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821065.pdf [firstpage_image] =>[orig_patent_app_number] => 576039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940423 [patent_doc_number] => 05973116 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Compounds for targeting' [patent_app_type] => 1 [patent_app_number] => 8/491988 [patent_app_country] => US [patent_app_date] => 1995-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 47 [patent_no_of_words] => 24207 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/973/05973116.pdf [firstpage_image] =>[orig_patent_app_number] => 491988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935566 [patent_doc_number] => 05939530 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Inhibitory and non-inhibitory antigen binding polypeptides against human P450 enzymes' [patent_app_type] => 1 [patent_app_number] => 8/559808 [patent_app_country] => US [patent_app_date] => 1995-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 11956 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939530.pdf [firstpage_image] =>[orig_patent_app_number] => 559808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3760581 [patent_doc_number] => 05843884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'C9 complement inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/559492 [patent_app_country] => US [patent_app_date] => 1995-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 10107 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843884.pdf [firstpage_image] =>[orig_patent_app_number] => 559492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3786912 [patent_doc_number] => 05780029 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Antidiotypic monoclonal antibodies for treatment of melanoma' [patent_app_type] => 1 [patent_app_number] => 8/549423 [patent_app_country] => US [patent_app_date] => 1995-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10968 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780029.pdf [firstpage_image] =>[orig_patent_app_number] => 549423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726558 [patent_doc_number] => 05635180 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Alteration of pharmacokinetics of proteins by charge modification' [patent_app_type] => 1 [patent_app_number] => 8/533675 [patent_app_country] => US [patent_app_date] => 1995-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 7748 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635180.pdf [firstpage_image] =>[orig_patent_app_number] => 533675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3756384 [patent_doc_number] => 05721105 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-24 [patent_title] => 'Method for the immunological determination of proteins and kit for carrying out the method' [patent_app_type] => 1 [patent_app_number] => 8/529880 [patent_app_country] => US [patent_app_date] => 1995-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5913 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/721/05721105.pdf [firstpage_image] =>[orig_patent_app_number] => 529880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404529 [patent_doc_number] => 06309636 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides' [patent_app_type] => 1 [patent_app_number] => 8/525539 [patent_app_country] => US [patent_app_date] => 1995-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 42 [patent_no_of_words] => 26785 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309636.pdf [firstpage_image] =>[orig_patent_app_number] => 525539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4372508 [patent_doc_number] => 06303120 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Synthesis of glycoconjugates of the lewis y epitope and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/506251 [patent_app_country] => US [patent_app_date] => 1995-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 51 [patent_no_of_words] => 36475 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303120.pdf [firstpage_image] =>[orig_patent_app_number] => 506251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3985816 [patent_doc_number] => 05891438 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Method for stimulating production of variable region gene family restricted antibodies through B-cell superantigen vaccination' [patent_app_type] => 1 [patent_app_number] => 8/428197 [patent_app_country] => US [patent_app_date] => 1995-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 29 [patent_no_of_words] => 21527 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891438.pdf [firstpage_image] =>[orig_patent_app_number] => 428197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3802366 [patent_doc_number] => 05830640 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Determining invasiveness of prostatic adenocarcinoma' [patent_app_type] => 1 [patent_app_number] => 8/486203 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18731 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830640.pdf [firstpage_image] =>[orig_patent_app_number] => 486203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3806991 [patent_doc_number] => 05811267 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Isolated nucleic acid molecules encoding antigen binding sites of antibody molecules specific for cancer antigens' [patent_app_type] => 1 [patent_app_number] => 8/475000 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20797 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811267.pdf [firstpage_image] =>[orig_patent_app_number] => 475000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220912 [patent_doc_number] => 06010861 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Target specific screens and their use for discovering small organic molecular pharmacophores' [patent_app_type] => 1 [patent_app_number] => 8/473105 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 31 [patent_no_of_words] => 51130 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010861.pdf [firstpage_image] =>[orig_patent_app_number] => 473105 [rel_patent_id] =>[rel_patent_doc_number] =>)